FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080559503> ?p ?o ?g. }

• W2080559503 endingPage "217" @default.
• W2080559503 startingPage "211" @default.
• W2080559503 abstract "To develop criteria for interpreting the high-dose dexamethasone suppression test using urine free cortisol as an end point for the differential diagnosis of the Cushing syndrome.Retrospective review.Inpatient research ward.Patients (118) with surgically confirmed causes of the Cushing syndrome: 94 with pituitary disease, 14 with primary adrenal disease, and 10 with ectopic adrenocorticotropic hormone (ACTH) secretion.The sensitivity, specificity, and diagnostic accuracy were determined for the high-dose dexamethasone suppression test using urine free cortisol and using 17-hydroxysteroid excretion. For each analysis, patients with pituitary disease were considered to be diseased and patients with nonpituitary disease were considered to be non-diseased. The level of suppression that gave 100% specificity was determined for each steroid.The accuracy of urine free cortisol when used as an end point in the high-dose dexamethasone suppression test was equivalent to that of 17-hydroxysteroid excretion. At all levels of sensitivity and specificity, however, the degree of suppression of urine free cortisol used for the diagnosis of pituitary disease was greater than that of 17-hydroxysteroid excretion. The likelihood ratios for pituitary disease based on urine free cortisol suppression of greater than 50%, of greater than 80%, and of greater than 90% were 4.2, 10.1, and infinite, respectively. Suppression of urine free cortisol greater than 90% or suppression of 17-hydroxysteroid excretion greater than 64% was associated with 100% specificity. When these criteria were combined, the percentage of correct predictions (102 of 118 [86%; 95% CI, 78% to 92%]) was higher than that obtained using either steroid alone (89 of 118 [75%; CI, 65% to 83%]) (P = 0.009) and higher than that obtained using the traditional criterion of 50% suppression for 17-hydroxysteroid excretion (95 of 118 [80%; CI, 71% to 87%]) (P = 0.016).In the high-dose dexamethasone suppression test, the degree of suppression of urine free cortisol used for the diagnosis of pituitary disease is greater than that traditionally used for 17-hydroxysteroid excretion. The diagnostic performance of the test is improved by measuring both urine free cortisol and 17-hydroxysteroid excretion and by requiring greater suppression of both steroids." @default.
• W2080559503 created "2016-06-24" @default.
• W2080559503 creator A5011872293 @default.
• W2080559503 creator A5025596266 @default.
• W2080559503 creator A5057724130 @default.
• W2080559503 creator A5059004606 @default.
• W2080559503 creator A5063830309 @default.
• W2080559503 creator A5065189585 @default.
• W2080559503 creator A5070165062 @default.
• W2080559503 creator A5073051973 @default.
• W2080559503 date "1992-02-01" @default.
• W2080559503 modified "2023-09-29" @default.
• W2080559503 title "Urine Free Cortisol in the High-Dose Dexamethasone Suppression Test for the Differential Diagnosis of the Cushing Syndrome" @default.
• W2080559503 cites W1909556934 @default.
• W2080559503 cites W1973552113 @default.
• W2080559503 cites W1987904636 @default.
• W2080559503 cites W1987995794 @default.
• W2080559503 cites W1990748933 @default.
• W2080559503 cites W1991970765 @default.
• W2080559503 cites W2002562101 @default.
• W2080559503 cites W2005168224 @default.
• W2080559503 cites W2014828064 @default.
• W2080559503 cites W2021930695 @default.
• W2080559503 cites W2054974876 @default.
• W2080559503 cites W2056581476 @default.
• W2080559503 cites W2060408085 @default.
• W2080559503 cites W2084310422 @default.
• W2080559503 cites W2086710277 @default.
• W2080559503 cites W2090712994 @default.
• W2080559503 cites W2090993393 @default.
• W2080559503 cites W2115173942 @default.
• W2080559503 cites W2134710296 @default.
• W2080559503 cites W2150336613 @default.
• W2080559503 cites W2151871224 @default.
• W2080559503 cites W2314557624 @default.
• W2080559503 doi "https://doi.org/10.7326/0003-4819-116-3-211" @default.
• W2080559503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1728204" @default.
• W2080559503 hasPublicationYear "1992" @default.
• W2080559503 type Work @default.
• W2080559503 sameAs 2080559503 @default.
• W2080559503 citedByCount "159" @default.
• W2080559503 countsByYear W20805595032012 @default.
• W2080559503 countsByYear W20805595032014 @default.
• W2080559503 countsByYear W20805595032015 @default.
• W2080559503 countsByYear W20805595032016 @default.
• W2080559503 countsByYear W20805595032017 @default.
• W2080559503 countsByYear W20805595032018 @default.
• W2080559503 countsByYear W20805595032019 @default.
• W2080559503 countsByYear W20805595032020 @default.
• W2080559503 countsByYear W20805595032021 @default.
• W2080559503 countsByYear W20805595032022 @default.
• W2080559503 countsByYear W20805595032023 @default.
• W2080559503 crossrefType "journal-article" @default.
• W2080559503 hasAuthorship W2080559503A5011872293 @default.
• W2080559503 hasAuthorship W2080559503A5025596266 @default.
• W2080559503 hasAuthorship W2080559503A5057724130 @default.
• W2080559503 hasAuthorship W2080559503A5059004606 @default.
• W2080559503 hasAuthorship W2080559503A5063830309 @default.
• W2080559503 hasAuthorship W2080559503A5065189585 @default.
• W2080559503 hasAuthorship W2080559503A5070165062 @default.
• W2080559503 hasAuthorship W2080559503A5073051973 @default.
• W2080559503 hasConcept C10146269 @default.
• W2080559503 hasConcept C126322002 @default.
• W2080559503 hasConcept C134018914 @default.
• W2080559503 hasConcept C2778709874 @default.
• W2080559503 hasConcept C2779435821 @default.
• W2080559503 hasConcept C2780026642 @default.
• W2080559503 hasConcept C2780401358 @default.
• W2080559503 hasConcept C2780455818 @default.
• W2080559503 hasConcept C2780546910 @default.
• W2080559503 hasConcept C71315377 @default.
• W2080559503 hasConcept C71924100 @default.
• W2080559503 hasConceptScore W2080559503C10146269 @default.
• W2080559503 hasConceptScore W2080559503C126322002 @default.
• W2080559503 hasConceptScore W2080559503C134018914 @default.
• W2080559503 hasConceptScore W2080559503C2778709874 @default.
• W2080559503 hasConceptScore W2080559503C2779435821 @default.
• W2080559503 hasConceptScore W2080559503C2780026642 @default.
• W2080559503 hasConceptScore W2080559503C2780401358 @default.
• W2080559503 hasConceptScore W2080559503C2780455818 @default.
• W2080559503 hasConceptScore W2080559503C2780546910 @default.
• W2080559503 hasConceptScore W2080559503C71315377 @default.
• W2080559503 hasConceptScore W2080559503C71924100 @default.
• W2080559503 hasIssue "3" @default.
• W2080559503 hasLocation W20805595031 @default.
• W2080559503 hasLocation W20805595032 @default.
• W2080559503 hasOpenAccess W2080559503 @default.
• W2080559503 hasPrimaryLocation W20805595031 @default.
• W2080559503 hasRelatedWork W1965311559 @default.
• W2080559503 hasRelatedWork W1987069610 @default.
• W2080559503 hasRelatedWork W2011741469 @default.
• W2080559503 hasRelatedWork W2052065831 @default.
• W2080559503 hasRelatedWork W2070317404 @default.
• W2080559503 hasRelatedWork W2091479231 @default.
• W2080559503 hasRelatedWork W2156430177 @default.
• W2080559503 hasRelatedWork W2158083719 @default.
• W2080559503 hasRelatedWork W2165534557 @default.
• W2080559503 hasRelatedWork W2170790420 @default.

• next